What is Myeloma?
Plasma cells are a type of white blood cell produced in the bone marrow, important for producing antibodies to fight infections. Myeloma begins when the DNA of a single plasma cell becomes damaged during its development, causing it to mutate into a cancerous cell. This abnormal cell then begins to multiply uncontrollably within the bone marrow, eventually crowding out the healthy red blood cells, white blood cells, and platelets that the body depends on.
When abnormal plasma cells get accumulated in the bone marrow, they disrupt the production of healthy blood cells, compromise bone integrity, and place considerable strain on the kidneys and the immune system.
Unlike many other cancers, myeloma does not form a single lump or tumour. Instead, it spreads to multiple sites in the body where bone marrow is usually active, including the bones of the pelvis, skull, rib cage, arms, and legs. This is why the condition is most often referred to as 'multiple myeloma'.
What are the Types of Myeloma?
Multiple myeloma is classified in several ways, such as by immunoglobulin type, gene mutation, and disease stage. Here is an overview of the main types of cancer:
-
Based on Disease Stage
Myeloma is divided into two stages based on whether it is causing symptoms or damage to the body:
- Smouldering Myeloma: At this stage, abnormal plasma cells and paraprotein are present in the body but have not yet caused any noticeable symptoms or damage to organs or tissues. Treatment is not usually required, but very close monitoring is essential, as the condition can progress. The risk of progression to active myeloma is highest within the first 5 years after diagnosis. After 5 years, the risk decreases, and some people never progress to needing treatment.
- Active Myeloma: When myeloma becomes active, it begins to cause symptoms such as bone pain and fatigue and can lead to organ damage, including bone lesions and kidney problems. Treatment is required at this stage.
-
Based on Immunoglobulin Type
Each myeloma case produces only one type of abnormal protein, known as a paraprotein or M protein. Antibodies are made up of two types of chains- larger heavy chains and smaller light chains – and myeloma is named after the specific combination present.
- IgG Myeloma: The most common type, accounting for the majority of myeloma cases. It is named after the G-type heavy chain present in the abnormal antibody. It can occur in combination with either a kappa or lambda light chain.
- IgA Myeloma: The second most common type, involving the A-type heavy chain. Like IgG, it occurs alongside either a kappa or lambda light chain.
- IgD, IgE, and IgM Myeloma: These types involve the D, E, and M heavy chains, respectively, and are considerably rarer. IgD and IgE myeloma in particular are uncommon, and IgM myeloma is the rarest of all.
- Light Chain Myeloma (Bence Jones Myeloma): In this type, the myeloma cells produce only the light chain portion of the antibody and not the heavy chain.
- Non-Secretory Myeloma: In rare cases, the myeloma cells produce little or no paraprotein at all, making the condition harder to detect through standard blood tests.
How Common is Myeloma in India?
According to the Global Cancer Observatory (GLOBOCAN) 2020, the five-year prevalence of multiple myeloma in India is approximately 2.2 cases per 1,00,000 people, compared with 5.78 per 1,00,000 globally. The disease accounts for around 1.23% of all cancers in the country and is responsible for nearly 5,900 deaths every year.
Globally, the median age of diagnosis is about 70 years, but in India, patients are diagnosed around a decade earlier. The country’s younger population structure is partly to blame, researchers say. The incidence of myeloma in young adults in India was 8.5%, which was higher than what has been reported in Western studies. The most common symptoms at presentation are bone pain and bony lesions, occurring in the vast majority of patients at diagnosis. Renal failure is another big issue, especially in older patients.
Symptoms of Myeloma
Myeloma is a cancer of plasma cells, a kind of white blood cell mostly found in the bone marrow. It may not cause symptoms at first, but when they do, they can affect the bones, blood levels, kidneys, calcium levels, and the body's ability to fight infections.
| Bone, Blood and Infection Symptoms | Organ and Metabolic Symptoms |
|
|
Stages of Myeloma
The Revised International Staging System (R-ISS) is the accepted method used to predict outcomes in multiple myeloma at diagnosis. Created by the International Myeloma Working Group, it looks at blood protein levels, kidney health, enzyme levels, and chromosome results to sort patients into one of three risk groups.
-
Stage 1: Lower-Risk Disease Test results of people in stage 1 suggest a lower risk of disease. Blood protein and enzyme levels are normal, and there are no harmful chromosomal changes. This group has the most favourable outlook.
-
Stage 2: Intermediate Risk Stage 2 is for people whose test results are not clearly low or high risk. Their blood and chromosome results fall in the middle risk category. This group has a moderate risk.
-
Stage 3: Higher-Risk Disease Stage 3 means the test results show high risk. Blood protein levels are high, and there may be risky chromosome changes or high enzyme levels. People in this group have the most serious outlook.
Related Diseases Comparison
Myeloma has similarities with other blood and plasma cell diseases, which can make your diagnosis difficult. Knowing how it is different from related conditions helps explain why special tests and expert evaluation are needed.
Myeloma vs AL Amyloidosis vs Non-Hodgkin Lymphoma
| Basis of Comparison | Myeloma | Amyloidosis | Non-Hodgkin Lymphoma |
| When it Happens? | Malignant plasma cells accumulate in the bone marrow and produce abnormal protein, leading to bone damage, kidney impairment, and other organ effects. | Misfolded light chains form amyloid deposits that damage organs; it can occur alongside plasma cell disorders, including myeloma. | Malignant lymphocytes arise in lymph nodes, lymphatic tissue, or sites outside the lymphatic system; some subtypes show plasma cell features that can resemble myeloma. |
| Location | Primarily bone marrow and bones, with secondary effects on kidneys, calcium balance, and blood counts. | Deposits can affect the heart, kidneys, liver, gastrointestinal tract, peripheral nerves, muscles, and soft tissues. | Typically lymph nodes, spleen, bone marrow, blood, or extranodal tissues, depending on the specific lymphoma subtype. |
| Associated Symptoms | Bone pain, fractures, fatigue, weakness, breathlessness, dizziness, infections, bleeding, thirst, frequent urination, constipation, confusion, itching, and leg swelling. | Kidney disease, nerve pain or numbness, heart failure symptoms, enlarged liver, enlarged tongue, bruising around the eyes, and carpal tunnel syndrome. | Swollen lymph nodes, fever, night sweats, weight loss, fatigue, abdominal swelling or pain, and chest symptoms when the disease affects those areas. |
| Severity | A chronic blood cancer with bone destruction, kidney impairment, infection risk, and a relapsing disease course. | Can be severe when deposits impair heart, kidney, nerve, or gastrointestinal function. | Impact varies widely by subtype; indolent forms may grow slowly, while aggressive forms require prompt treatment. |
| Can it be Reversed? | Generally managed with drug combinations, stem cell transplant in eligible patients, and maintenance therapy; treatment aims for remission and relapse control rather than guaranteed cure. | Treatment targets the plasma cell clone to reduce amyloid production; existing organ damage may improve, stabilise, or persist depending on the organ and timing of treatment. | Some subtypes are curable with treatment, while others are controlled over time; outcome depends on lymphoma subtype and treatment response. |
Medicines Used to Treat Myeloma
Myeloma cannot be cured for most patients right now, but it is treated with combinations of medicines that aim to put the disease in remission, control relapses, and provide supportive care.
-
Proteasome inhibitors, such as bortezomib
-
Immunomodulatory drugs, including lenalidomide and thalidomide
-
Corticosteroids, like dexamethasone
-
Alkylating chemotherapy, including cyclophosphamide and melphalan
-
CD38-directed monoclonal antibodies, such as daratumumab
-
Bone-modifying agents, including zoledronic acid
Living with Myeloma in India: Daily Challenges, Financial Burden, and Caregiver Support
Living with myeloma is hard physically, emotionally, and financially. But with the right treatment and support, many people can manage their myeloma symptoms and keep a good quality of life.
-
Daily Challenges Myeloma causes many symptoms like bone pain, weakness, broken bones, tiredness, risk of infection, and kidney problems. These can make walking, doing housework, sleeping, and travelling for treatment harder.
-
Financial Considerations Treatment costs in India go far beyond hospital bills. Medicine costs make up most of what patients pay out of pocket, with travel and tests making up the rest. For patients needing an autologous stem cell transplant, out-of-pocket costs include earlier chemotherapy.
-
Mental Well-being The mental stress of myeloma is large and lasts through the whole illness, from diagnosis to each treatment and as the disease changes. Mental health checkups and support are recommended at key times, such as the start and end of each treatment cycle.
-
Caregiver Support Caregivers of people with myeloma have a heavy load emotionally, mentally, physically, financially, and socially. Both patients and caregivers face ongoing challenges and need support, especially during and after treatment.
-
Mobility and Safety With myeloma, bones become fragile and are prone to fractures, even with a small injury. Fractures often happen in the back, hips, or skull. Call a doctor immediately if you have sudden confusion, dizziness, weakness on one side of the body, or slurred speech. These symptoms may be related to decreased blood flow to the brain.
-
Monitoring and Follow-up Regular monitoring with blood tests, urine tests, bone marrow checks, and scans is essential to follow how your disease responds and to spot any changes. If your new bone symptoms appear, scans should be done quickly.
Myeloma Treatment Cost in India
Myeloma treatment often goes on for a long time. Costs can rise if the disease gets worse, comes back, needs bone support, or if a stem cell transplant is needed.
| Treatment | Cost Range |
| Haematologist Consultation | ₹1,000 to ₹2,500 per consultation |
| Serum Protein Electrophoresis | ₹719 to ₹989 per test |
| Whole-Body PET CT Scan | ₹4,600 to ₹31,000 per scan |
| Thalidomide Capsules | ₹447 to ₹633 per strip of 10 capsules |
| Lenalidomide Capsules | ₹2,534 to ₹7,687 per pack |
| Zoledronic Acid Injection | ₹809 to ₹2,266 per injection |
| Autologous Stem Cell Transplant | ₹2,25,000 to ₹2,47,400 per transplant episode |
Disclaimer: The numbers are example costs and can change depending on city, provider, and treatment plan.
What Causes Myeloma?
Myeloma begins when a plasma cell in the bone marrow undergoes a genetic mutation, causing it to behave abnormally. Instead of following the normal cycle of growth and death, the mutated cell begins dividing uncontrollably, producing large numbers of cancerous myeloma cells.
As myeloma cells get collected in the bone marrow, the production of healthy red blood cells, white blood cells, and platelets gets disrupted and the body cannot function normally. Myeloma cells continue to produce antibodies, as normal plasma cells do, but the antibodies they make, known as M proteins, are abnormal and serve no useful purpose. Instead, they accumulate in the body and can damage the kidneys and other organs.
The cause of this sudden mutation is unknown. These mutations are acquired rather than inherited and develop after birth. They appear to develop spontaneously over a person's lifetime, which may explain why the disease is more commonly diagnosed in older adults.
Risk Factors of Myeloma
While the exact cause of myeloma is not fully understood, certain factors are known to increase the likelihood of developing the disease.
-
Older Age: Myeloma is primarily seen in those who have crossed the age of 50, with the majority of cases occurring in the late 60s.
-
Gender: Men are more likely to be diagnosed with multiple myeloma than women as per research.
-
Family History: Having a parent or sibling with myeloma may increase the risk, although the disease is not usually inherited.
-
Developing MGUS: MGUS is a condition where the plasma cells start producing M proteins. Those with MGUS have a greater chance of developing multiple myeloma over time.
-
Obesity: Research has linked being overweight to an increased risk of developing myeloma.
-
Exposure to Harmful Chemicals or Radiation: Long-term exposure to pesticides, fertilisers, radiation, or certain industrial chemicals and metals may increase the risk of developing myeloma.
-
High-Risk Occupations: Some studies suggest that people working in occupations with frequent exposure to chemicals or smoke, such as firefighting, may have a higher risk of developing myeloma.
What are the Complications of Myeloma?
If myeloma is not treated or progresses over time, it can affect several organs and body systems, leading to serious health complications.
-
Frequent Infections: Myeloma weakens the immune system, making the body more vulnerable to repeated infections, especially bacterial infections such as pneumonia.
-
Bone Damage: The disease can weaken bones, causing persistent bone pain, thinning of the bones, and increasing the risk of fractures.
-
Kidney Damage: Abnormal proteins produced by myeloma cells can harm the kidneys and, in severe cases, lead to kidney failure.
-
Anaemia: Myeloma can reduce the production of healthy red blood cells. This can cause anaemia, leading to tiredness, weakness, and other blood-related problems.
-
High Calcium Levels (Hypercalcaemia): Bone breakdown can release excess calcium into the bloodstream, resulting in hypercalcaemia, which may require urgent medical treatment.
-
Peripheral Neuropathy: Peripheral nerve damage can cause numbness, tingling, pain, or increased sensitivity in the hands and feet. This may result from the disease itself or its treatment.
-
Amyloidosis: Abnormal proteins produced by myeloma can accumulate in organs, interfering with their normal function.
-
Cryoglobulinaemia: Certain abnormal proteins may damage blood vessels and interfere with normal blood circulation.
-
Hyperviscosity Syndrome: Excess proteins in the blood can make it unusually thick, reducing blood flow and requiring emergency medical care.
-
Spinal Cord Compression: Weakened bones in the spine can press the spinal cord, leading to pain, weakness, or nerve-related problems that require immediate treatment.
When Should I See My Healthcare Provider?
If you have symptoms that may be a sign of myeloma, see your healthcare provider as soon as you can. Early diagnosis increases the chances of better treatment outcomes. If you have already been diagnosed, stay in regular touch with your doctor and tell them immediately if you develop any new or worsening symptoms or side effects of treatment. The doctor can also explain what symptoms to expect during treatment, which symptoms will need a routine appointment and which symptoms may need immediate emergency medical attention.
How is Myeloma Diagnosed?
Doctors diagnose myeloma by combining your medical history, physical examination, laboratory investigations, imaging studies, and bone marrow testing, as no single test can confirm the disease.
-
Medical Checkup The first step is a discussion with a doctor about your symptoms, medical history, and family history of cancer (if any), along with a physical examination. If myeloma is suspected, you may be referred to a haematologist for further evaluation.
-
Blood, Urine, and Imaging Tests Blood and urine tests help detect abnormal proteins produced by myeloma cells and assess blood cell counts, kidney function, and calcium levels. Imaging tests, like X-rays, CT scans, MRI scans, or PET scans, may be used to look for bone damage or tumours.
-
Bone Marrow Biopsy A small sample of bone marrow, usually taken from the hip bone, is observed under a microscope to look for abnormal plasma cells and confirm the diagnosis. Doctors may analyse the bone marrow sample to identify genetic changes in the myeloma cells.
How is Myeloma Treated?
Treatment for myeloma depends on the stage of the cancer, the severity of symptoms, and the patient's overall health. Common treatment options include:
-
Monitoring: If myeloma is at an early stage and not causing symptoms, doctors may recommend regular blood and urine tests along with periodic check-ups to monitor the disease before starting treatment.
-
Targeted Therapy: These medicines target specific proteins or pathways in myeloma cells, helping destroy cancer cells while limiting damage to healthy tissues.
-
Immunotherapy: This treatment strengthens the body's immune system so it can better recognise and attack myeloma cells.
-
CAR T-Cell Therapy: In this advanced form of immunotherapy, a patient's own T cells are modified in a laboratory and returned to the body to identify and kill myeloma cells.
-
Chemotherapy: Powerful anti-cancer medicines are used to destroy rapidly growing myeloma cells and are often given before a stem cell transplant.
-
Corticosteroids: Steroid medicines help reduce inflammation and also work directly against myeloma cells. They are commonly used along with other treatments.
-
Stem Cell Transplant: This procedure replaces damaged bone marrow with healthy blood-forming stem cells, usually collected from the patient's own body. It is also called a ‘bone marrow transplant’.
-
Radiation Therapy: This therapy uses radiation to shrink tumours, relieve bone pain, and treat areas where the cancer has damaged the bones.
Can Myeloma be Prevented?
There is no guaranteed way to prevent myeloma because the exact reason why healthy plasma cells become cancerous is still not fully understood. However, here are a few things you can do:
-
Maintain a Healthy Weight: Being overweight is associated with an increased risk of myeloma, so maintaining a healthy body weight may be beneficial.
-
Follow a Healthy Lifestyle: Eat a balanced and nutritious diet, exercise regularly, avoid smoking, and limit alcohol consumption to support your overall health.
-
Minimise Exposure to Harmful Chemicals and Radiation: If possible, avoid unnecessary exposure to radiation and to chemicals such as certain pesticides, fertilisers, and other hazardous substances linked to a higher risk of myeloma.
-
Focus on Early Detection: Since most risk factors, such as age and family history, cannot be changed, paying attention to persistent symptoms and seeking timely medical evaluation can help with earlier diagnosis and treatment.
What is the Prognosis of Myeloma?
Although there is currently no permanent cure for myeloma, advances in treatment have significantly improved survival and quality of life for many patients. The prognosis looks different in every case, depending on the cancer stage, the person's overall health, and how well the cancer responds to treatment.
In general, people diagnosed at an early stage tend to have a much better prognosis than those diagnosed after the disease has become more advanced. The overall five-year survival rate for myeloma is about 62%. However, when the condition is detected early, the five-year survival rate increases to around 80%. Many people are also able to live for 10 years or longer with appropriate treatment and regular follow-up care.
Does Health Insurance Cover Myeloma?
Yes, health insurance covers the treatment of blood cancers like myeloma. Most policies cover hospital room rent, surgeon's fees, medicines, diagnostic tests, ambulance expenses, and specified pre- and post-hospitalisation expenses.
Critical illness plans also cover blood cancers, offering a lump-sum payment that you can use for treatment costs. You become eligible for a payout after diagnosis, subject to a waiting period of 90 to 180 days and a survival period of 7 to 30 days. In fact, some insurers also offer dedicated cancer insurance plans that provide coverage for pre-existing cancer after the predetermined waiting period is over.
To understand the exact inclusions, exclusions, and other conditions of your policy, you must read all policy documents carefully.
How Much Health Insurance is Required for Myeloma?
Cancer treatment involves surgical procedures, long-term radiation therapy, chemotherapy, etc. A health insurance coverage of at least ₹10 lakh to ₹20 lakh is ideal, considering the high cost of many of these treatments.
However, if you are at higher risk for myeloma because of family history, age or other factors, you should consider opting for a higher sum insured.
FAQs
-
Q1. Is myeloma a serious cancer?
Ans: Yes, myeloma is a serious and life-threatening blood cancer. It affects the ability of the body to make normal blood cells, it affects the bones, it affects the kidneys, it affects the immune system. But progress in treatment has dramatically improved survival and quality of life for many patients. -
Q2. Can I live a normal life with myeloma?
Ans: The ability of a myeloma patient to live a normal life depends on the stage of the disease and its severity. Many people with myeloma are able to live for 5 to 10 years or even longer with early diagnosis, appropriate treatment and regular follow-up care. -
Q3. What are the first symptoms of myeloma?
Ans: Early symptoms can include persistent bone pain, particularly in the back, spine, or hips; overwhelming fatigue and weakness; and recurring infections, and in some cases, the disease may produce no symptoms at all in its early stages, making it difficult to detect.
-
References
-
https://www.cancer.gov/types/myeloma/hp/myeloma-treatment-pdq
-
https://www.apollo247.com/specialties/haematologists
-
https://pmc.ncbi.nlm.nih.gov/articles/PMC5280872/
-
https://www.cancerresearchuk.org/about-cancer/myeloma/stages
-
